PDS Biotechnology Announces Conference Call and Webcast to Present Third-Quarter 2021 Financial Results
FLORHAM PARK, N.J., Oct. 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, will release financial results for the third quarter of 2021 on Wednesday, November 10, 2021, before the market opens. Following the release, management will host a conference call to review the company’s financial results and provide a business update.
The conference call is scheduled to begin at 8:00 am ET on Wednesday, November 10, 2021. Participants should dial 877-407-3088 (United States) or 201-389-0927 (International) and mention PDS Biotechnology. A live webcast of the conference call will also be available on the investor relations page of the Company's website at www.pdsbiotech.com.
After the live webcast, the event will be archived on PDS Biotech’s website for 6 months.
About PDS Biotechnology
Forward Looking Statements
Media & Investor Relations Contact:
#TECHSUPERSHOW Keynote Presentation - Open to all Badge Holders
Asset Management â€“ Keeping Remote Devices Connected
Keynote Panel Session - Open to all Badge Holders